Oyster Point Pharma, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2019-02-27: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-02-15; Total offering amount $92,999,999.
- 2017-10-25: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-10-11; Total offering amount $43,125,784.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2019-02-27 | Rule 506(b) | Equity | 2019-02-15 | $92,999,999 | $84,999,985 | $8,000,014 | 7 |
| 2017-10-25 | Rule 506(b) | Equity | 2017-10-11 | $43,125,784 | $28,614,800 | $14,510,984 | 8 |